|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
1 April 2013 |
|
Main ID: |
NCT00194428 |
|
Date of registration:
|
14/09/2005 |
|
Primary sponsor: |
|
|
Public title:
|
Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese Persons
|
|
Scientific title:
|
Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese Persons |
|
Date of first enrolment:
|
February 2005 |
|
Target sample size:
|
123 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00194428 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Gary D Foster, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Temple University |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Body mass index (BMI) > 27 but <40
- 18-75 years of age
- Men and non-pregnant or lactating women
- Subjects must be willing to comply with all study-related procedures
Exclusion Criteria:
- Uncontrolled hypertension
- Diabetes or use of anti-hyperglycemic medication
- Dyslipidemia requiring prescription drug therapy as defined by NCEP ATPIII guidelines at screening
- Known allergy or sensitivity to nuts
- Known atherosclerotic cardiovascular disease
- History of congestive heart failure
- History of a non-skin malignancy within the previous 5 years
- Any major active rheumatologic, pulmonary, hepatic, renal, dermatologic disease or inflammatory condition
- History of being HIV positive
- History of alcohol or drug abuse
- Weight-loss inducing medications or dietary supplements within 3 months prior to enrollment.
- Weight loss > 5 kg during the last 6 months
- Participation in an investigational drug study within 6 weeks prior to screening
- Serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's safety or successful participation in the study
Age minimum:
18 Years
Age maximum:
75 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Hyperlipidemia
|
|
Hypertension
|
|
Metabolic Syndrome X
|
|
Obesity
|
|
Intervention(s)
|
|
Behavioral: Almond enriched diet
|
|
Behavioral: Low fat caloric diet
|
|
Primary Outcome(s)
|
|
To evaluate the effects of an almond-enriched (2 oz/day) hypocaloric, low-fat diet on body weight and body composition in overweight and obese persons
[Time Frame: 6 months]
|
|
Secondary Outcome(s)
|
|
To evaluate the effects of the almond enriched diet on established and emerging surrogate markers of coronoary artery disease (CAD) risk
[Time Frame: 6 months]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|